About ITP
Childhood ITP
Teenage ITP
Adult ITP
Medical Advisors
Research into ITP

Events
Convention
Seminar

Send for:-
Publications
Information Pack
Hospital Information
Items for Sale
American Perspective

Search this site

Join us

Nplate (Romiplostim)

Nplate (Romiplostim) has not been approved by NICE for use in the NHS for the treatment of ITP.

The ITP Support Association’s membership ranges from some whose disease is mild and well controlled to others with a severe and life threatening condition who are refractory to current treatments. For the latter group there is a great need for a new approach and many have their hopes pinned on Nplate becoming available throughout the UK.

We are disappointed with the decision of NICE but recognise it has a very difficult job to do, particularly in the current climate of economic downturn. Pharmaceutical companies are required to take their drugs through an increasing number of hoops and hurdles to apply for a licence and we then complain that their drugs are too expensive for the NHS. The ITP Support Association sees no easy answer, but nevertheless, believes that a case should be made for this drug that could be life-saving for a limited number of people.

Further information about Nplate can be found by following these links:-

The NHS, National Electronic Library for Medicines (NeLM)

NeLM (Scotland).
SMC accepts restricted use of romiplostim (Nplate®) for chronic ITP

National Institute for Health and Clinical Excellence (NICE)

Google results from only the NICE website